Keywords: Novavax, Cadila, Vaccine production plant, India

Novavax and Cadila complete construction of vaccine production facility in India

Article | 11 June 2010

Print This

CPL Biologicals (CPLB), a joint venture of India’s Cadila Pharmaceuticals and US clinical-stage biotechnology firm Novavax, says that it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in